The evaluation of the biologic implications of hormone response potential in malignant as well as beningn and dysplastic lesions of the human mammary gland have been hampered by technological difficulties relating to the heterogeneity of the human breast and its disorders. The development of an effective immunocytochemical techniques for the evaluation of at least one step in the pathway of sex steroid action makes possible the study of the tissue components contributing to the tissue reponse potential and/or degree of tissue differentiation. The present projectg proposes to use a monoclonal antibody directed against estrogen receptor (H222) on material which has been collected over the past eight years and stored at -80 C from over 1000 cases which have been carefully characterized clinically at the time of the surgical resection of the tissue and with follow-up of the clinical course of these patients thorugh periods up to 8 years. The pattern of localization of H222 method will be compared to menstrual cycle data for primary tumors, beningn and dysplastic lesions, and to clinical response to hormone therapy for metastatic disease. The prognostic significance of the pattern of localization of such antigentically defined estrogen receptor will be tested by analyses of material from primary breast cancers with follow-up from initial resection to disease recurrence for disease free interval and survival with a follow-up period of a minimum of five years. The overall goal of this project will be to establish whether heterogeneity in distribution of antigentically defined receptor in comparison to the biochemical quantitation of estrogen and progesterone receptor carries additional biologically significant and prognostic information. The comparison of apparent receptor heterogeneity with elements of the tumor with different histology will serve to evaluate if components of a tumor are associated with greater propensity to demonstrate the receptor protein and whether this information carries additional prognostic information beyond quantitative receptor analysis or tumor grade alone, controlling for tumor stage.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA038989-02
Application #
3177556
Study Section
Pathology B Study Section (PTHB)
Project Start
1985-01-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Kinsel, L B; Szabo, E; Greene, G L et al. (1989) Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res 49:1052-6
Boyer, C M; Borowitz, M J; McCarty Jr, K S et al. (1989) Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells. Int J Cancer 43:55-60
Bacus, S; Flowers, J L; Press, M F et al. (1988) The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 90:233-9
Mutch, D G; Soper, J T; Budwit-Novotny, D A et al. (1987) Endometrial adenocarcinoma estrogen receptor content: association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methods. Am J Obstet Gynecol 157:924-31
Flowers, J L; Seigler, H F; McCarty Sr, K S et al. (1987) Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody. Arch Dermatol 123:764-5
Mold, D E; McCarty Sr, K S (1987) A Chinese hamster ovary cell histone deacetylase that is associated with a unique class of mononucleosomes. Biochemistry 26:8257-62
Burton, G V; Flowers, J L; Cox, E B et al. (1987) Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: a marker of hormone response. Breast Cancer Res Treat 10:287-91
Ferguson, B J; Hudson, W R; McCarty Jr, K S (1987) Sex steroid receptor distribution in the human larynx and laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 113:1311-5
McCarty Jr, K S; Szabo, E; Flowers, J L et al. (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46:4244s-4248s
Budwit-Novotny, D A; McCarty, K S; Cox, E B et al. (1986) Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 46:5419-25

Showing the most recent 10 out of 12 publications